These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11285146)

  • 21. Changes in the duration and frequency of deviant stimuli engender different mismatch negativity patterns in temporal lobe epilepsy.
    Hirose Y; Hara K; Miyajima M; Matsuda A; Maehara T; Hara M; Matsushima E; Ohta K; Matsuura M
    Epilepsy Behav; 2014 Feb; 31():136-42. PubMed ID: 24412859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain potential evidence for an auditory sensory memory deficit in schizophrenia.
    Catts SV; Shelley AM; Ward PB; Liebert B; McConaghy N; Andrews S; Michie PT
    Am J Psychiatry; 1995 Feb; 152(2):213-9. PubMed ID: 7840354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mismatch Negativity (MMN) and schizophrenia: a revision].
    Mondragón-Maya A; Bernal-Hernández J; Yáñez-Téllez G; Rodríguez-Agudelo Y
    Actas Esp Psiquiatr; 2011; 39(6):363-73. PubMed ID: 22127909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Auditory hallucinations and the mismatch negativity: processing speech and non-speech sounds in schizophrenia.
    Fisher DJ; Labelle A; Knott VJ
    Int J Psychophysiol; 2008 Oct; 70(1):3-15. PubMed ID: 18511139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual mismatch negativity among patients with schizophrenia.
    Urban A; Kremlácek J; Masopust J; Libiger J
    Schizophr Res; 2008 Jul; 102(1-3):320-8. PubMed ID: 18472402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patients.
    Horton J; Millar A; Labelle A; Knott VJ
    Schizophr Res; 2011 Mar; 126(1-3):202-11. PubMed ID: 21194893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of deviance predictability on mismatch negativity in schizophrenia patients.
    Horacek M; Kärgel C; Scherbaum N; Müller BW
    Neurosci Lett; 2016 Mar; 617():76-81. PubMed ID: 26861199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of auditory deviance detection by acute nicotine is baseline and deviant dependent in healthy nonsmokers: a mismatch negativity study.
    Knott V; Impey D; Philippe T; Smith D; Choueiry J; de la Salle S; Dort H
    Hum Psychopharmacol; 2014 Sep; 29(5):446-58. PubMed ID: 25196041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic effects of cannabis use on the auditory mismatch negativity.
    Greenwood LM; Broyd SJ; Croft R; Todd J; Michie PT; Johnstone S; Murray R; Solowij N
    Biol Psychiatry; 2014 Mar; 75(6):449-58. PubMed ID: 23830666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mismatch negativity in tobacco-naïve cannabis users and its alteration with acute nicotine administration.
    Impey D; El-Marj N; Parks A; Choueiry J; Fisher D; Knott VJ
    Pharmacol Biochem Behav; 2015 Sep; 136():73-81. PubMed ID: 26188167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mismatch negativity of ERP in cross-modal attention.
    Luo Y; Wei J
    Sci China C Life Sci; 1997 Dec; 40(6):604-12. PubMed ID: 18726284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transdermal nicotine administration enhances automatic auditory processing reflected by mismatch negativity.
    Inami R; Kirino E; Inoue R; Arai H
    Pharmacol Biochem Behav; 2005 Mar; 80(3):453-61. PubMed ID: 15740788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Event-related potentials in schizophrenic patients in the acute phase and in remission].
    Eikmeier G; Lodemann E; Zerbin D; Gastpar M
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1991 Mar; 22(1):15-20. PubMed ID: 1864244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impulsivity affects mismatch negativity (MMN) measures of preattentive auditory processing.
    Franken IH; Nijs I; Van Strien JW
    Biol Psychol; 2005 Dec; 70(3):161-7. PubMed ID: 16242534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests.
    Felipo V; Ordoño JF; Urios A; El Mlili N; Giménez-Garzó C; Aguado C; González-Lopez O; Giner-Duran R; Serra MA; Wassel A; Rodrigo JM; Salazar J; Montoliu C
    Hepatology; 2012 Feb; 55(2):530-9. PubMed ID: 21953369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.
    Harvey PD; Rabinowitz J; Eerdekens M; Davidson M
    Am J Psychiatry; 2005 Oct; 162(10):1888-95. PubMed ID: 16199835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The value of cognitive psychophysiological studies in a comprehensive approach to schizophrenia (treatment of information and attention capacities in acute-stage schizophrenia)].
    Lembreghts M; Timsit-Berthier M
    Acta Psychiatr Belg; 1993; 93 Spec No():322-42. PubMed ID: 8091994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central auditory dysfunction in schizophrenia as revealed by the mismatch negativity (MMN) and its magnetic equivalent MMNm: a review.
    Näätänen R; Kähkönen S
    Int J Neuropsychopharmacol; 2009 Feb; 12(1):125-35. PubMed ID: 18771603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risperidone and Cognitive Functioning in Elderly Schizophrenic Patients(Dr. Madhusoodanan comments).
    Madhusoodanan S
    Am J Geriatr Psychiatry; 2000 May; 8(2):178-179. PubMed ID: 10843655
    [No Abstract]   [Full Text] [Related]  

  • 40. Connecting Neurobiological Features with Interregional Dysconnectivity in Social-Cognitive Impairments of Schizophrenia.
    Adraoui FW; Douw L; Martens GJM; Maas DA
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.